Natco takes patent blitz honed in India to US pharma market
Natco expects to be among the first to win regulatory approval for its Copaxone generic, with sales anticipated to start in the next six months09-04-2015
Natco takes patent blitz honed in India to US pharma market
Natco expects to be among the first to win regulatory approval for its Copaxone generic, with sales anticipated to start in the next six monthsShareholding Pattern For March 31, 2015
Natco Pharma Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Natco Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Natco receives Generic Sofosbuvir (Sovaldi) approval for India
Natco Pharma Ltd has informed BSE regarding a Press Release dated March 12, 2015, titled "Natco receives Generic Sofosbuvir (Sovaldi) approval for India".Supreme Court Agrees with NATCO and Denies petition for Certiorari on Generic Tamiflu Patent
Natco Pharma Ltd has informed BSE regarding a Press Release dated March 10, 2015, titled "Supreme Court Agrees with NATCO and Denies petition for Certiorari on Generic Tamiflu Patent".NATCO launches HEPCINAT in Nepal- 1st generic version of Sofosbuvir (Sovaldi) in the country
Natco Pharma Ltd has informed BSE regarding a Press Release dated March 09, 2015 titled "NATCO launches HEPCINAT in Nepal- 1st generic version of Sofosbuvir (Sovaldi) in the country".NATCO announces Licensing Agreement with Gilead Sciences
Natco Pharma Ltd has informed BSE regarding a Press Release dated March 02, 2015, titled "NATCO announces Licensing Agreement with Gilead Sciences".NATCO announces USFDA Filing for Sorafenib Tablets, 200mg
Natco Pharma Ltd has informed BSE regarding a Press Release dated February 11, 2015 titled "NATCO announces USFDA Filing for Sorafenib Tablets, 200mg".Results Press Release
Natco Pharma Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2014.Fixes Record Date for Interim Dividend
Natco Pharma Ltd has informed BSE that the Company has fixed February 25, 2015 as the Record Date for the purpose of Payment of Interim Dividend. The said interim dividend pay-by-date is March 06, 2015.